Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Chalon, S
   Polyunsaturated fatty acids and cognitive functions
   OCL-OLEAGINEUX CORPS GRAS LIPIDES
   
   S. Chalon, "Polyunsaturated fatty acids and cognitive functions", OCL-OL CORP, 8(4), 2001, pp. 317-320
2. Emond, P; Helfenbein, J; Chalon, S; Garreau, L; Vercouillie, J; Frangin, Y; Besnard, JC; Guilloteau, D
   Synthesis of tropane and nortropane analogues with phenyl substitutions asserotonin transporter ligands
   BIOORGANIC & MEDICINAL CHEMISTRY
   
   P. Emond et al., "Synthesis of tropane and nortropane analogues with phenyl substitutions asserotonin transporter ligands", BIO MED CH, 9(7), 2001, pp. 1849-1855
3. Vancassel, S; Durand, G; Barthelemy, C; Lejeune, B; Martineau, J; Guilloteau, D; Andres, C; Chalon, S
   Plasma fatty acid levels in autistic children
   PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
   
   S. Vancassel et al., "Plasma fatty acid levels in autistic children", PROS LEUK E, 65(1), 2001, pp. 1-7
4. Vercouillie, J; Tarkiainen, S; Halldin, C; Emond, P; Chalon, S; Sandell, J; Langer, O; Guilloteau, D
   Precursor synthesis and radiolabelling of [C-11]ADAM: A potential radioligand for the serotonin transporter exploration by PET
   JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
   
   J. Vercouillie et al., "Precursor synthesis and radiolabelling of [C-11]ADAM: A potential radioligand for the serotonin transporter exploration by PET", J LABEL C R, 44(2), 2001, pp. 113-120
5. Bezard, E; Boraud, T; Chalon, S; Brotchie, JM; Guilloteau, D; Gross, CE
   Pallidal border cells: An anatomical and electrophysiological study in the1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey
   NEUROSCIENCE
   
   E. Bezard et al., "Pallidal border cells: An anatomical and electrophysiological study in the1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey", NEUROSCIENC, 103(1), 2001, pp. 117-123
6. Bezard, E; Dovero, S; Prunier, C; Ravenscroft, P; Chalon, S; Guilloteau, D; Crossman, AR; Bioulac, B; Brotchie, JM; Gross, CE
   Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease
   JOURNAL OF NEUROSCIENCE
   
   E. Bezard et al., "Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease", J NEUROSC, 21(17), 2001, pp. 6853-6861
7. Prunier, C; Tranquart, F; Cottier, JP; Giraudeau, B; Chalon, S; Guilloteau, D; De Toffol, B; Chossat, F; Autret, A; Besnard, JC; Baulieu, JL
   Quantitative analysis of striatal dopamine D2 receptors with I-123-iodolisuride SPECT in degenerative extrapyramidal diseases
   NUCLEAR MEDICINE COMMUNICATIONS
   
   C. Prunier et al., "Quantitative analysis of striatal dopamine D2 receptors with I-123-iodolisuride SPECT in degenerative extrapyramidal diseases", NUCL MED C, 22(11), 2001, pp. 1207-1214
8. Chalon, S; Vancassel, S; Zimmer, L; Guilloteau, D; Durand, G
   Polyunsaturated fatty acids and cerebral function: Focus on monoaminergic neurotransmission
   LIPIDS
   
   S. Chalon et al., "Polyunsaturated fatty acids and cerebral function: Focus on monoaminergic neurotransmission", LIPIDS, 36(9), 2001, pp. 937-944
9. Cantagrel, S; Gressens, P; Bodard, S; Suc, AL; Laugier, J; Guilloteau, D; Chalon, S
   MRNA D-2 dopaminergic receptor expression after hypoxia-ischemia in rat immature brain
   BIOLOGY OF THE NEONATE
   
   S. Cantagrel et al., "MRNA D-2 dopaminergic receptor expression after hypoxia-ischemia in rat immature brain", BIOL NEONAT, 80(1), 2001, pp. 68-73
10. Chalon, S
    N-3 polyunsaturated fatty acids, neurotransmission and cognitive functions
    OCL-OLEAGINEUX CORPS GRAS LIPIDES
    
    S. Chalon, "N-3 polyunsaturated fatty acids, neurotransmission and cognitive functions", OCL-OL CORP, 7(1), 2000, pp. 68-73
11. Gouhier, C; Chalon, S; Venier-Julienne, MC; Bodard, S; Benoit, JP; Besnard, JC; Guilloteau, D
    Neuroprotection of nerve growth factor-loaded microspheres on the D2 dopaminergic receptor positive-striatal neurones in quinolinic acid-lesioned rats: a quantitative autoradiographic assessment with iodobenzamide
    NEUROSCIENCE LETTERS
    
    C. Gouhier et al., "Neuroprotection of nerve growth factor-loaded microspheres on the D2 dopaminergic receptor positive-striatal neurones in quinolinic acid-lesioned rats: a quantitative autoradiographic assessment with iodobenzamide", NEUROSCI L, 288(1), 2000, pp. 71-75
12. Zimmer, L; Delpal, S; Guilloteau, D; Aioun, J; Durand, G; Chalon, S
    Chronic n-3 polyunsaturated fatty acid deficiency alters dopamine vesicle density in the rat frontal cortex
    NEUROSCIENCE LETTERS
    
    L. Zimmer et al., "Chronic n-3 polyunsaturated fatty acid deficiency alters dopamine vesicle density in the rat frontal cortex", NEUROSCI L, 284(1-2), 2000, pp. 25-28
13. Zimmer, L; Kodas, E; Guilloteau, D; Garreau, L; Besnard, JC; Chalon, S
    Microdialysis as a tool for in vivo study of dopamine transporter functionin rat brains
    JOURNAL OF NEUROSCIENCE METHODS
    
    L. Zimmer et al., "Microdialysis as a tool for in vivo study of dopamine transporter functionin rat brains", J NEUROSC M, 103(2), 2000, pp. 137-144
14. Zimmer, L; Delion-Vancassel, S; Durand, G; Guilloteau, D; Bodard, S; Besnard, JC; Chalon, S
    Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n-3 polyunsaturated fatty acids
    JOURNAL OF LIPID RESEARCH
    
    L. Zimmer et al., "Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n-3 polyunsaturated fatty acids", J LIPID RES, 41(1), 2000, pp. 32-40
15. Chalon, S; Moreno, H; Benowitz, NL; Hoffman, BB; Blaschke, TF
    Nicotine impairs endothelium-dependent dilatation in human veins in vivo
    CLINICAL PHARMACOLOGY & THERAPEUTICS
    
    S. Chalon et al., "Nicotine impairs endothelium-dependent dilatation in human veins in vivo", CLIN PHARM, 67(4), 2000, pp. 391-397
16. Tangphao, O; Chalon, S; Coulston, AM; Moreno, H; Chan, JR; Cooke, JP; Hoffman, BB; Blaschke, TF
    L-arginine and nitric oxide-related compounds in plasma: comparison of normal and arginine-free diets in a 24-h crossover study
    VASCULAR MEDICINE
    
    O. Tangphao et al., "L-arginine and nitric oxide-related compounds in plasma: comparison of normal and arginine-free diets in a 24-h crossover study", VASC MED, 4(1), 1999, pp. 27-32
17. Chalon, S; Berlin, I; Sachon, C; Bosquet, F; Grimaldi, A
    Propranolol in hypoglycaemia unawareness
    DIABETES & METABOLISM
    
    S. Chalon et al., "Propranolol in hypoglycaemia unawareness", DIABETE MET, 25(1), 1999, pp. 23-26
18. Hall, H; Halldin, C; Guilloteau, D; Chalon, S; Emond, P; Besnard, JC; Farde, L; Sedvall, G
    Visualization of the dopamine transporter in the human brain postmortem with the new selective ligand [I-125]PE2I
    NEUROIMAGE
    
    H. Hall et al., "Visualization of the dopamine transporter in the human brain postmortem with the new selective ligand [I-125]PE2I", NEUROIMAGE, 9(1), 1999, pp. 108-116
19. Helfenbein, J; Sandell, J; Halldin, C; Chalon, S; Emond, P; Okubo, Y; Chou, YH; Frangin, Y; Douziech, L; Gareau, L; Swahn, CG; Besnard, JC; Farde, L; Guilloteau, D
    PET examination of three potent cocaine derivatives as specific radioligands for the serotonin transporter
    NUCLEAR MEDICINE AND BIOLOGY
    
    J. Helfenbein et al., "PET examination of three potent cocaine derivatives as specific radioligands for the serotonin transporter", NUCL MED BI, 26(5), 1999, pp. 491-499
20. Chalon, S; Cantagrel, S
    Monoaminergic neurotransmission and brain disorders in newborn and young children
    ARCHIVES DE PEDIATRIE
    
    S. Chalon e S. Cantagrel, "Monoaminergic neurotransmission and brain disorders in newborn and young children", ARCH PED, 6, 1999, pp. 197S-198S
21. Chalon, S; Emond, P; Bodard, S; Vilar, MP; Thiercelin, C; Besnard, JC; Guilloteau, D
    Time course of changes in striatal dopamine transporters and D-2 receptorswith specific iodinated markers in a rat model of Parkinson's disease
    SYNAPSE
    
    S. Chalon et al., "Time course of changes in striatal dopamine transporters and D-2 receptorswith specific iodinated markers in a rat model of Parkinson's disease", SYNAPSE, 31(2), 1999, pp. 134-139
22. Helfenbein, J; Emond, P; Loc'h, C; Bottlaender, M; Ottaviani, M; Guilloteau, D; Maziere, B; Frangin, Y; Chalon, S
    Synthesis of (E)-N-(3-bromoprop-2-enyl)-2 beta-carbomethoxy-3 beta-(4 '-tolyl) nortropane (PE2Br) and radiolabelling of [Br-76]PE2Br: A potential ligand for exploration of the dopamine transporter by PET.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    
    J. Helfenbein et al., "Synthesis of (E)-N-(3-bromoprop-2-enyl)-2 beta-carbomethoxy-3 beta-(4 '-tolyl) nortropane (PE2Br) and radiolabelling of [Br-76]PE2Br: A potential ligand for exploration of the dopamine transporter by PET.", J LABEL C R, 42(6), 1999, pp. 581-588
23. Helfenbein, J; Emond, P; Sandell, J; Halldin, C; Pereyre, S; Frangin, Y; Garreau, L; Besnard, JC; Guilloteau, D; Chalon, S
    Synthesis and radiolabelling of 2 beta-carbomethoxy-3 beta-(3 '-iodo-4 '-isopropylphenyl) nortropane as a radioligand for the exploration of the serotonin transporter by SPET.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    
    J. Helfenbein et al., "Synthesis and radiolabelling of 2 beta-carbomethoxy-3 beta-(3 '-iodo-4 '-isopropylphenyl) nortropane as a radioligand for the exploration of the serotonin transporter by SPET.", J LABEL C R, 42(4), 1999, pp. 337-347
24. Tangphao, O; Grossmann, M; Chalon, S; Hoffman, BB; Blaschke, TF
    Pharmacokinetics of intravenous and oral L-arginine in normal volunteers
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    
    O. Tangphao et al., "Pharmacokinetics of intravenous and oral L-arginine in normal volunteers", BR J CL PH, 47(3), 1999, pp. 261-266
25. Chalon, S; Tejura, B; Moreno, H; Urae, A; Blaschke, TF; Hoffman, BB
    Role of nitric oxide in isoprenaline and sodium nitroprusside-induced relaxation in human hand veins
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    
    S. Chalon et al., "Role of nitric oxide in isoprenaline and sodium nitroprusside-induced relaxation in human hand veins", BR J CL PH, 47(1), 1999, pp. 91-98
26. Tangphao, O; Chalon, S; Moreno, H; Hoffman, BB; Blaschke, TF
    Pharmacokinetics of L-arginine during chronic administration to patients with hypercholesterolaemia
    CLINICAL SCIENCE
    
    O. Tangphao et al., "Pharmacokinetics of L-arginine during chronic administration to patients with hypercholesterolaemia", CLIN SCI, 96(2), 1999, pp. 199-207
27. Zimmer, L; Durand, G; Guilloteau, D; Chalon, S
    n-3 polyunsaturated fatty acid deficiency and dopamine metabolism in the rat frontal cortex
    LIPIDS
    
    L. Zimmer et al., "n-3 polyunsaturated fatty acid deficiency and dopamine metabolism in the rat frontal cortex", LIPIDS, 34, 1999, pp. S251-S251
28. Helfenbein, J; Loc'h, C; Bottlaender, M; Emond, P; Coulon, C; Ottaviani, M; Fuseau, C; Chalon, S; Guenther, I; Besnard, JC; Frangin, Y; Guilloteau, D; Maziere, B
    A selective radiobrominated cocaine analogue for imaging of dopamine uptake sites: Pharmacological evaluation and PET experiments
    LIFE SCIENCES
    
    J. Helfenbein et al., "A selective radiobrominated cocaine analogue for imaging of dopamine uptake sites: Pharmacological evaluation and PET experiments", LIFE SCI, 65(25), 1999, pp. 2715-2726
29. Chalon, S; Garreau, L; Emond, P; Zimmer, L; Vilar, MP; Besnard, JC; Guilloteau, D
    Pharmacological characterization of (E)-N-(3-iodoprop-2-enyl)-2 beta-carboxymethoxy-3 beta-(4 '-methylphenyl)nortropane as a selective and potent inhibitor of the neuronal dopamine transporter
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    
    S. Chalon et al., "Pharmacological characterization of (E)-N-(3-iodoprop-2-enyl)-2 beta-carboxymethoxy-3 beta-(4 '-methylphenyl)nortropane as a selective and potent inhibitor of the neuronal dopamine transporter", J PHARM EXP, 291(2), 1999, pp. 648-654
30. Tangphao, O; Chalon, S; Moreno, HJ; Abiose, AK; Blaschke, TF; Hoffman, BB
    Heparin-induced vasodilation in human hand veins
    CLINICAL PHARMACOLOGY & THERAPEUTICS
    
    O. Tangphao et al., "Heparin-induced vasodilation in human hand veins", CLIN PHARM, 66(3), 1999, pp. 232-238
31. Chalon, S; Moreno, H; Hoffman, BB; Blaschke, TF
    Angiotensin-converting enzyme inhibition improves venous endothelial dysfunction in chronic smokers
    CLINICAL PHARMACOLOGY & THERAPEUTICS
    
    S. Chalon et al., "Angiotensin-converting enzyme inhibition improves venous endothelial dysfunction in chronic smokers", CLIN PHARM, 65(3), 1999, pp. 295-303
32. Chalon, S; Bedarida, GV; Moreno, H; Tejura, B; Urae, A; Hoffmann, BB; Blaschke, TF
    Inhibition of angiotensin-converting enzyme in human hand veins
    CLINICAL PHARMACOLOGY & THERAPEUTICS
    
    S. Chalon et al., "Inhibition of angiotensin-converting enzyme in human hand veins", CLIN PHARM, 65(1), 1999, pp. 58-65
33. GUILLOTEAU D; EMOND P; BAULIEU JL; GARREAU L; FRANGIN Y; POURCELOT L; MAUCLAIRE L; BESNARD JC; CHALON S
    EXPLORATION OF THE DOPAMINE TRANSPORTER - IN-VITRO AND IN-VIVO CHARACTERIZATION OF A HIGH-AFFINITY AND HIGH-SPECIFICITY IODINATED TROPANE DERIVATIVE TA-CARBOMETHOXY-3-BETA-(4'-METHYLPHENYL)NORTROPANE (PE2I)
    Nuclear medicine and biology
    
    D. Guilloteau et al., "EXPLORATION OF THE DOPAMINE TRANSPORTER - IN-VITRO AND IN-VIVO CHARACTERIZATION OF A HIGH-AFFINITY AND HIGH-SPECIFICITY IODINATED TROPANE DERIVATIVE TA-CARBOMETHOXY-3-BETA-(4'-METHYLPHENYL)NORTROPANE (PE2I)", Nuclear medicine and biology, 25(4), 1998, pp. 331-337
34. EMOND P; FARDE L; CHALON S; BELZUNG C; MAUCLAIRE V; CHIRON JP; HALLDIN C; BESNARD JC; GUILLOTEAU D
    TOXICITY, MUTAGENICITY, AND BEHAVIORAL-EFFECTS OF BETA-CIT, A LIGAND FOR DOPAMINE TRANSPORTER EXPLORATION BY SPECT
    Nuclear medicine and biology
    
    P. Emond et al., "TOXICITY, MUTAGENICITY, AND BEHAVIORAL-EFFECTS OF BETA-CIT, A LIGAND FOR DOPAMINE TRANSPORTER EXPLORATION BY SPECT", Nuclear medicine and biology, 25(4), 1998, pp. 405-409
35. CHALON S; EMOND P; BESNARD JC; GUILLOTEAU D
    TIME-COURSE OF CHANGES IN THE DOPAMINE TRANSPORTERS AND D-2 RECEPTORSIN A RAT MODEL OF PARKINSONS-DISEASE
    European journal of neuroscience
    
    S. Chalon et al., "TIME-COURSE OF CHANGES IN THE DOPAMINE TRANSPORTERS AND D-2 RECEPTORSIN A RAT MODEL OF PARKINSONS-DISEASE", European journal of neuroscience, 10, 1998, pp. 6907-6907
36. BELZUNG C; CRETON C; CHALON S; DELIONVANCASSEL S
    EFFECT OF ICV OR INTRA-RAPHE-5 - 7-DIHYDROXYTRYPTAMINE PERFUSION ON STATE AND TRAIT ANXIETY IN BALB C MICE/
    European journal of neuroscience
    
    C. Belzung et al., "EFFECT OF ICV OR INTRA-RAPHE-5 - 7-DIHYDROXYTRYPTAMINE PERFUSION ON STATE AND TRAIT ANXIETY IN BALB C MICE/", European journal of neuroscience, 10, 1998, pp. 16207-16207
37. MORENO H; CHALON S; URAE A; TANGPHAO O; ABIOSE AK; HOFFMAN BB; BLASCHKE TF
    ENDOTHELIAL DYSFUNCTION IN HUMAN HAND VEINS IS RAPIDLY REVERSIBLE AFTER SMOKING CESSATION
    American journal of physiology. Heart and circulatory physiology
    
    H. Moreno et al., "ENDOTHELIAL DYSFUNCTION IN HUMAN HAND VEINS IS RAPIDLY REVERSIBLE AFTER SMOKING CESSATION", American journal of physiology. Heart and circulatory physiology, 44(3), 1998, pp. 1040-1045
38. KUIKKA JT; BAULIEU JL; HILTUNEN J; HALLDIN C; BERGSTROM KA; FARDE L; EMOND P; CHALON S; YU MX; NIKULA T; LAITINEN T; KARHU J; TUPALA E; HALLIKAINEN T; KOLEHMAINEN V; MAUCLAIRE L; MAZIERE B; TIIHONEN J; GUILLOTEAU D
    PHARMACOKINETICS AND DOSIMETRY OF I-123 LABELED PE2I IN HUMANS, A RADIOLIGAND FOR DOPAMINE TRANSPORTER IMAGING
    European journal of nuclear medicine
    
    J.T. Kuikka et al., "PHARMACOKINETICS AND DOSIMETRY OF I-123 LABELED PE2I IN HUMANS, A RADIOLIGAND FOR DOPAMINE TRANSPORTER IMAGING", European journal of nuclear medicine, 25(5), 1998, pp. 531-534
39. ZIMMER L; HEMBERT S; DURAND G; BRETON P; GUILLOTEAU D; BESNARD JC; CHALON S
    CHRONIC N-3 POLYUNSATURATED FATTY-ACID DIET-DEFICIENCY ACTS ON DOPAMINE METABOLISM IN THE RAT FRONTAL-CORTEX - A MICRODIALYSIS STUDY
    Neuroscience letters
    
    L. Zimmer et al., "CHRONIC N-3 POLYUNSATURATED FATTY-ACID DIET-DEFICIENCY ACTS ON DOPAMINE METABOLISM IN THE RAT FRONTAL-CORTEX - A MICRODIALYSIS STUDY", Neuroscience letters, 240(3), 1998, pp. 177-181
40. HUGUET F; GUERRAOUI A; BARRIER L; GUILLOTEAU D; TALLINEAU C; CHALON S
    CHANGES IN EXCITATORY AMINO-ACID LEVELS AND TISSUE ENERGY METABOLITESOF NEONATE RAT-BRAIN AFTER HYPOXIA AND HYPOXIA-ISCHEMIA
    Neuroscience letters
    
    F. Huguet et al., "CHANGES IN EXCITATORY AMINO-ACID LEVELS AND TISSUE ENERGY METABOLITESOF NEONATE RAT-BRAIN AFTER HYPOXIA AND HYPOXIA-ISCHEMIA", Neuroscience letters, 240(2), 1998, pp. 102-106
41. Page, G; Chalon, S; Barrier, L; Piriou, A; Huguet, F
    Characterization of both dopamine uptake systems in rat striatal slices byspecific pharmacological tools
    NEUROCHEMISTRY INTERNATIONAL
    
    G. Page et al., "Characterization of both dopamine uptake systems in rat striatal slices byspecific pharmacological tools", NEUROCHEM I, 33(5), 1998, pp. 459-466
42. ZIMMER L; EMOND P; FRANGIN Y; CHALON S; BESNARD JC; GUILLOTEAU D
    SPECIFICITY OF PE2I, ANEW COCAINE DERIVATE FOR DOPAMINE TRANSPORTER IMAGING - AN IN-VIVO STUDY BY DUAL-PROBE MICRODIALYSIS
    The Journal of nuclear medicine
    
    L. Zimmer et al., "SPECIFICITY OF PE2I, ANEW COCAINE DERIVATE FOR DOPAMINE TRANSPORTER IMAGING - AN IN-VIVO STUDY BY DUAL-PROBE MICRODIALYSIS", The Journal of nuclear medicine, 39(5), 1998, pp. 187-187
43. HALLDIN C; GUILLOTEAU D; OKUBO Y; LUNDKVIST C; OLSSON H; KARLSSON P; CHALON S; EMOND P; SWAHN CG; FARDE L
    PET-CHARACTERIZATION OF [C-11] PE2I BINDING TO DOPAMINE TRANSPORTER IN THE MONKEY BRAIN
    The Journal of nuclear medicine
    
    C. Halldin et al., "PET-CHARACTERIZATION OF [C-11] PE2I BINDING TO DOPAMINE TRANSPORTER IN THE MONKEY BRAIN", The Journal of nuclear medicine, 39(5), 1998, pp. 463-463
44. SANDELL J; HELFENBEIN J; HALLDIN C; OKUBO Y; CHALON S; FRANGIN Y; GALINIER E; SWAHN CG; GUILLOTEAU D; FARDE L
    PRECURSOR SYNTHESIS, RADIOLABELING AND PET EXAMINATION IN MONKEY OF 3POTENT SEROTONIN TRANSPORTER RADIOLIGANDS
    The Journal of nuclear medicine
    
    J. Sandell et al., "PRECURSOR SYNTHESIS, RADIOLABELING AND PET EXAMINATION IN MONKEY OF 3POTENT SEROTONIN TRANSPORTER RADIOLIGANDS", The Journal of nuclear medicine, 39(5), 1998, pp. 469-469
45. HELFENBEIN J; BOTTLAENDER M; COULON C; EDMOND P; OTTAVIANI M; FUSEAU C; CHALON S; LOCH C; FRANGIN Y; GUILLOTEAU D; MAZIERE B
    PHARMACOLOGICAL EVALUATION AND PET STUDIES OF BR-76-PE2BR, A HIGHLY SELECTIVE RADIOBROMINATED COCAINE ANALOG FOR QUANTITATION OF DOPAMINE UPTAKE SITES
    The Journal of nuclear medicine
    
    J. Helfenbein et al., "PHARMACOLOGICAL EVALUATION AND PET STUDIES OF BR-76-PE2BR, A HIGHLY SELECTIVE RADIOBROMINATED COCAINE ANALOG FOR QUANTITATION OF DOPAMINE UPTAKE SITES", The Journal of nuclear medicine, 39(5), 1998, pp. 1050-1050
46. FAVRELIERE S; BARRIER L; DURAND G; CHALON S; TALLINEAU C
    CHRONIC DIETARY N-3 POLYUNSATURATED FATTY-ACIDS DEFICIENCY AFFECTS THE FATTY-ACID COMPOSITION OF PLASMENYLETHANOLAMINE AND PHOSPHATIDYLETHANOLAMINE DIFFERENTLY IN RAT FRONTAL-CORTEX, STRIATUM, AND CEREBELLUM
    Lipids
    
    S. Favreliere et al., "CHRONIC DIETARY N-3 POLYUNSATURATED FATTY-ACIDS DEFICIENCY AFFECTS THE FATTY-ACID COMPOSITION OF PLASMENYLETHANOLAMINE AND PHOSPHATIDYLETHANOLAMINE DIFFERENTLY IN RAT FRONTAL-CORTEX, STRIATUM, AND CEREBELLUM", Lipids, 33(4), 1998, pp. 401-407
47. BELZUNG C; LEGUISQUET AM; BARREAU S; DELIONVANCASSEL S; CHALON S; DURAND G
    ALPHA-LINOLENIC ACID DEFICIENCY MODIFIES DISTRACTIBILITY BUT NOT ANXIETY AND LOCOMOTION IN RATS DURING AGING
    The Journal of nutrition
    
    C. Belzung et al., "ALPHA-LINOLENIC ACID DEFICIENCY MODIFIES DISTRACTIBILITY BUT NOT ANXIETY AND LOCOMOTION IN RATS DURING AGING", The Journal of nutrition, 128(9), 1998, pp. 1537-1542
48. Chalon, S; Delion-Vancassel, S; Belzung, C; Guilloteau, D; Leguisquet, AM; Besnard, JC; Durand, G
    Dietary fish oil affects monoaminergic neurotransmission and behavior in rats
    JOURNAL OF NUTRITION
    
    S. Chalon et al., "Dietary fish oil affects monoaminergic neurotransmission and behavior in rats", J NUTR, 128(12), 1998, pp. 2512-2519
49. CHALON S; MORENO H; BLASCHKE TF; HOFFMAN BB
    ACE-INHIBITION IMPROVES ENDOTHELIAL FUNCTION IN CHRONIC SMOKERS
    Clinical pharmacology and therapeutics
    
    S. Chalon et al., "ACE-INHIBITION IMPROVES ENDOTHELIAL FUNCTION IN CHRONIC SMOKERS", Clinical pharmacology and therapeutics, 63(2), 1998, pp. 2-2
50. TANGPHAO O; COULSTON AM; MORENO H; CHALON S; CHAN JR; COOKE JP; BLASCHKE TF; HOFFMAN BB
    DIURNAL-VARIATION OF PLASMA L-ARGININE CONCENTRATIONS AND THE EFFECT OF DIETARY L-ARGININE INTAKE
    Clinical pharmacology and therapeutics
    
    O. Tangphao et al., "DIURNAL-VARIATION OF PLASMA L-ARGININE CONCENTRATIONS AND THE EFFECT OF DIETARY L-ARGININE INTAKE", Clinical pharmacology and therapeutics, 63(2), 1998, pp. 25-25
51. LECHAT P; PACKER M; CHALON S; CUCHERAT M; ARAB T; BOISSEL JP
    CLINICAL EFFECTS OF BETA-ADRENERGIC-BLOCKADE IN CHRONIC HEART-FAILURE- A METAANALYSIS OF DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED TRIALS
    Circulation
    
    P. Lechat et al., "CLINICAL EFFECTS OF BETA-ADRENERGIC-BLOCKADE IN CHRONIC HEART-FAILURE- A METAANALYSIS OF DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED TRIALS", Circulation, 98(12), 1998, pp. 1184-1191
52. EMOND P; CHALON S; GARREAU L; DOGNON AM; BODARD S; FRANGIN Y; BAULIEU JL; BESNARD JC; GUILLOTEAU D
    A NEW IODINATED TROPANE DERIVATIVE (BETA-CDIT) FOR IN-VIVO DOPAMINE TRANSPORTER EXPLORATION - COMPARISON WITH BETA-CIT
    Synapse
    
    P. Emond et al., "A NEW IODINATED TROPANE DERIVATIVE (BETA-CDIT) FOR IN-VIVO DOPAMINE TRANSPORTER EXPLORATION - COMPARISON WITH BETA-CIT", Synapse, 26(1), 1997, pp. 72-80
53. EMOND P; BOAZI M; DUCHENE A; CHALON S; BESNARD JC; GUILLOTEAU D; FRANGIN Y
    SYNTHESIS OF IODINATED AND RADIOIODINATED -2-BETA-CARBOMETHOXY-3-BETA-(3',4'-DICHLOROPHENYL) NORTROPANE (BETA-CDIT) - A LIGAND FOR THE DOPAMINE TRANSPORTER
    Journal of labelled compounds & radiopharmaceuticals
    
    P. Emond et al., "SYNTHESIS OF IODINATED AND RADIOIODINATED -2-BETA-CARBOMETHOXY-3-BETA-(3',4'-DICHLOROPHENYL) NORTROPANE (BETA-CDIT) - A LIGAND FOR THE DOPAMINE TRANSPORTER", Journal of labelled compounds & radiopharmaceuticals, 39(9), 1997, pp. 757-772
54. RAHALPEROLA V; REVIERS MTH; CHALON S; BODARD S; GUILLOTEAU D; HAMAMAH S; LANSAC J; ROYERE D
    DOES NEONATAL HYPOXIA-ISCHEMIA INFLUENCE MALE REPRODUCTIVE DEVELOPMENT AND FUNCTION
    Human reproduction
    
    V. Rahalperola et al., "DOES NEONATAL HYPOXIA-ISCHEMIA INFLUENCE MALE REPRODUCTIVE DEVELOPMENT AND FUNCTION", Human reproduction, 12, 1997, pp. 7-7
55. CHALON S; EMOND P; THIERCELIN C; BODARD S; GARREAU L; FRANGIN Y; MAUCLAIRE L; BESNARD JC; GUILLOTEAU D
    ROP-2E-ENYL)-2-BETA-CARBOMETHOXY-3-BETA-(4'-METHYL PHENYL) NORTROPANEAS A SELECTIVE MARKER FOR THE DOPAMINE TRANSPORTER - VALIDATION IN A RAT MODEL OF PARKINSONS-DISEASE
    The Journal of nuclear medicine
    
    S. Chalon et al., "ROP-2E-ENYL)-2-BETA-CARBOMETHOXY-3-BETA-(4'-METHYL PHENYL) NORTROPANEAS A SELECTIVE MARKER FOR THE DOPAMINE TRANSPORTER - VALIDATION IN A RAT MODEL OF PARKINSONS-DISEASE", The Journal of nuclear medicine, 38(5), 1997, pp. 279-279
56. GUILLOTEAU D; CHALON S; BLAUENSTEIN P; BAULIEU JL; BESNARD JC; SCHUBIGER PA
    MONOAMINE-OXIDASE-B EXPLORATION BY SPET - WHY AND HOW
    The Journal of nuclear medicine
    
    D. Guilloteau et al., "MONOAMINE-OXIDASE-B EXPLORATION BY SPET - WHY AND HOW", The Journal of nuclear medicine, 38(5), 1997, pp. 780-780
57. GARREAU L; EMOND P; BELZUNG C; GUILLOTEAU D; FRANGIN Y; BESNARD JC; CHALON S
    RBOMETHOXY-3-BETA-(3',4'-DICHLOROPHENYL)NORTROPANE (BETA-CDIT), A TROPANE DERIVATIVE - PHARMACOLOGICAL CHARACTERIZATION AS A SPECIFIC LIGAND FOR THE DOPAMINE TRANSPORTER IN THE RODENT BRAIN
    The Journal of pharmacology and experimental therapeutics
    
    L. Garreau et al., "RBOMETHOXY-3-BETA-(3',4'-DICHLOROPHENYL)NORTROPANE (BETA-CDIT), A TROPANE DERIVATIVE - PHARMACOLOGICAL CHARACTERIZATION AS A SPECIFIC LIGAND FOR THE DOPAMINE TRANSPORTER IN THE RODENT BRAIN", The Journal of pharmacology and experimental therapeutics, 282(1), 1997, pp. 467-474
58. EMOND P; GARREAU L; CHALON S; BOAZI M; CAILLET M; BRICARD J; FRANGIN Y; MAUCLAIRE L; BESNARD JC; GUILLOTEAU D
    SYNTHESIS AND LIGAND-BINDING OF NORTROPANE DERIVATIVES - N-SUBSTITUTED BETA-CARBOMETHOXY-3-BETA-(4'-IODOPHENYL)NORTROPANE AND L)-2-BETA-CARBOMETHOXY-3-BETA-(3',4'-DISUBSTITUTED PHENYL)NORTROPANE - NEW HIGH-AFFINITY AND SELECTIVE COMPOUNDS FOR THE DOPAMINE TRANSPORTER
    Journal of medicinal chemistry
    
    P. Emond et al., "SYNTHESIS AND LIGAND-BINDING OF NORTROPANE DERIVATIVES - N-SUBSTITUTED BETA-CARBOMETHOXY-3-BETA-(4'-IODOPHENYL)NORTROPANE AND L)-2-BETA-CARBOMETHOXY-3-BETA-(3',4'-DISUBSTITUTED PHENYL)NORTROPANE - NEW HIGH-AFFINITY AND SELECTIVE COMPOUNDS FOR THE DOPAMINE TRANSPORTER", Journal of medicinal chemistry, 40(9), 1997, pp. 1366-1372
59. DELION S; CHALON S; GUILLOTEAU D; LEJEUNE B; BESNARD JC; DURAND G
    AGE-RELATED-CHANGES IN PHOSPHOLIPID FATTY-ACID COMPOSITION AND MONOAMINERGIC NEUROTRANSMISSION IN THE HIPPOCAMPUS OF RATS FED A BALANCED ORAN N-3 POLYUNSATURATED FATTY ACID-DEFICIENT DIET
    Journal of lipid research
    
    S. Delion et al., "AGE-RELATED-CHANGES IN PHOSPHOLIPID FATTY-ACID COMPOSITION AND MONOAMINERGIC NEUROTRANSMISSION IN THE HIPPOCAMPUS OF RATS FED A BALANCED ORAN N-3 POLYUNSATURATED FATTY ACID-DEFICIENT DIET", Journal of lipid research, 38(4), 1997, pp. 680-689
60. PELLEVOISIN C; CHALON S; KUNG HF; BESNARD JC; GUILLOTEAU D
    IS TISCH A SUITABLE TRACER FOR IN-VIVO STUDY OF MODIFICATIONS OF THE DOPAMINE D-1 RECEPTOR
    Nuclear medicine and biology
    
    C. Pellevoisin et al., "IS TISCH A SUITABLE TRACER FOR IN-VIVO STUDY OF MODIFICATIONS OF THE DOPAMINE D-1 RECEPTOR", Nuclear medicine and biology, 23(1), 1996, pp. 75-78
61. CHALON S; PELLEVOISIN C; BODARD S; VILAR MP; BESNARD JC; GUILLOTEAU D
    IODINATED PK-11195 AS AN EX-VIVO MARKER OF NEURONAL INJURY IN THE LESIONED RAT-BRAIN
    Synapse
    
    S. Chalon et al., "IODINATED PK-11195 AS AN EX-VIVO MARKER OF NEURONAL INJURY IN THE LESIONED RAT-BRAIN", Synapse, 24(4), 1996, pp. 334-339
62. PELLEVOISIN C; GUILLOTEAU D; BAULIEU JL; LOCH C; DOGNON AM; MAUCLAIRE L; SACCAVINI JC; BESNARD JC; CHALON S
    IODALISURIDE AND IODOBENZAMIDE, 2 LIGANDS FOR SPECT EXPLORATION OF THE DOPAMINERGIC D2 RECEPTORS - A COMPARATIVE-STUDY
    Synapse
    
    C. Pellevoisin et al., "IODALISURIDE AND IODOBENZAMIDE, 2 LIGANDS FOR SPECT EXPLORATION OF THE DOPAMINERGIC D2 RECEPTORS - A COMPARATIVE-STUDY", Synapse, 24(1), 1996, pp. 79-86
63. EMOND P; GARREAU L; CHALON S; BOAZI M; FRANGIN Y; BESNARD JC; GUILLOTEAU D
    THE BETA-CDIT, A NEW COCAINE CONGENER FOR DOPAMINE TRANSPORTER EXPLORATION WITH HIGH SPECIFICITY AND VALUABLE IN-VIVO KINETIC
    The Journal of nuclear medicine
    
    P. Emond et al., "THE BETA-CDIT, A NEW COCAINE CONGENER FOR DOPAMINE TRANSPORTER EXPLORATION WITH HIGH SPECIFICITY AND VALUABLE IN-VIVO KINETIC", The Journal of nuclear medicine, 37(5), 1996, pp. 853-853
64. CHALON S; BRUDI P; LECHAT P
    TREATMENT OF ESSENTIAL-HYPERTENSION - ONG OING RANDOMIZED CONTROLLED TRIALS
    Therapie
    
    S. Chalon et al., "TREATMENT OF ESSENTIAL-HYPERTENSION - ONG OING RANDOMIZED CONTROLLED TRIALS", Therapie, 51(6), 1996, pp. 631-638
65. ZOUAKIA A; GUILLOTEAU D; ZIMMER L; BESNARD JC; CHALON S
    EVOLUTION OF DOPAMINE-RECEPTORS IN THE RAT AFTER NEONATAL HYPOXIA-ISCHEMIA - AUTORADIOGRAPHIC STUDIES
    Life sciences
    
    A. Zouakia et al., "EVOLUTION OF DOPAMINE-RECEPTORS IN THE RAT AFTER NEONATAL HYPOXIA-ISCHEMIA - AUTORADIOGRAPHIC STUDIES", Life sciences, 60(2), 1996, pp. 151-162
66. RAFII H; CHALON S; OMBETTA JE; FRANGIN Y; POURCELOT L; BESNARD JC; BODARD S; GUILLOTEAU D
    AN IODINATED DERIVATIVE OF MOCLOBEMIDE AS POTENTIAL RADIOLIGAND FOR BRAIN MAO-A EXPLORATION
    Life sciences
    
    H. Rafii et al., "AN IODINATED DERIVATIVE OF MOCLOBEMIDE AS POTENTIAL RADIOLIGAND FOR BRAIN MAO-A EXPLORATION", Life sciences, 58(14), 1996, pp. 1159-1169
67. DELION S; CHALON S; GUILLOTEAU D; BESNARD JC; DURAND G
    ALPHA-LINOLENIC ACID DIETARY DEFICIENCY ALTERS AGE-RELATED-CHANGES OFDOPAMINERGIC AND SEROTONINERGIC NEUROTRANSMISSION IN THE RAT FRONTAL-CORTEX
    Journal of neurochemistry
    
    S. Delion et al., "ALPHA-LINOLENIC ACID DIETARY DEFICIENCY ALTERS AGE-RELATED-CHANGES OFDOPAMINERGIC AND SEROTONINERGIC NEUROTRANSMISSION IN THE RAT FRONTAL-CORTEX", Journal of neurochemistry, 66(4), 1996, pp. 1582-1591
68. LECHAT PP; CHALON S; CUCHERAT M; PACKER M; BOISSEL JP
    METAANALYSIS OF RANDOMIZED CLINICAL-TRIALS ON BETA-BLOCKER TREATMENT IN HEART-FAILURE
    Circulation
    
    P.P. Lechat et al., "METAANALYSIS OF RANDOMIZED CLINICAL-TRIALS ON BETA-BLOCKER TREATMENT IN HEART-FAILURE", Circulation, 94(8), 1996, pp. 3883-3883
69. CHALON S; LECHAT P
    ANTITHROMBOTIC TREATMENT IN ATRIAL-FIBRIL LATION
    Archives des maladies du coeur et des vaisseaux
    
    S. Chalon e P. Lechat, "ANTITHROMBOTIC TREATMENT IN ATRIAL-FIBRIL LATION", Archives des maladies du coeur et des vaisseaux, 89(11), 1996, pp. 1533-1542
70. LENA I; OMBETTA JE; CHALON S; DOGNON AM; BAULIEU JL; FRANGIN Y; GARREAU L; BESNARD JC; GUILLOTEAU D
    IODODERIVATIVE OF PARGYLINE - A POTENTIAL TRACER FOR THE EXPLORATION OF MONOAMINE-OXIDASE SITES BY SPECT
    Nuclear medicine and biology
    
    I. Lena et al., "IODODERIVATIVE OF PARGYLINE - A POTENTIAL TRACER FOR THE EXPLORATION OF MONOAMINE-OXIDASE SITES BY SPECT", Nuclear medicine and biology, 22(6), 1995, pp. 727-736
71. RAFII H; CHALON S; OMBETTA JE; FRANGIN Y; GARREAU L; DOGNON AM; LENA I; BODARD S; VILAR MP; BESNARD JC; GUILLOTEAU D
    SYNTHESIS AND CHARACTERIZATION OF [I-125] N-(2-AMINOETHYL)-4-IODOBENZAMIDE SELECTIVE AS A MONOAMINE-OXIDASE-B INHIBITOR
    Nuclear medicine and biology
    
    H. Rafii et al., "SYNTHESIS AND CHARACTERIZATION OF [I-125] N-(2-AMINOETHYL)-4-IODOBENZAMIDE SELECTIVE AS A MONOAMINE-OXIDASE-B INHIBITOR", Nuclear medicine and biology, 22(5), 1995, pp. 617-623
72. BRANGER C; GARREAU L; DOGNON AM; FRANGIN Y; CAILLET M; OMBETTAGOKA JE; CHALON S; BESNARD JC; GUILLOTEAU D
    SYNTHESIS OF 4'-IODO-5-METHOXY-VALEROPHENONE O-(2-AMINOETHYL)OXIME ASAN AGENT FOR EXPLORATION OF SEROTONINERGIC TRANSPORTER
    Nuclear medicine and biology
    
    C. Branger et al., "SYNTHESIS OF 4'-IODO-5-METHOXY-VALEROPHENONE O-(2-AMINOETHYL)OXIME ASAN AGENT FOR EXPLORATION OF SEROTONINERGIC TRANSPORTER", Nuclear medicine and biology, 22(2), 1995, pp. 157-164
73. BRANGER C; GARREAU L; FRANGIN Y; CHALON S; DUBOIS P; DOGNON AM; OMBETTAGOKA JE; BESNARD JC; GUILLOTEAU D
    RADIOIODINATED ANALOGS OF XYLAMINE - N-(2-CHLOROETHYL)-N-ETHYL-2-[I-125]IODOBENZYLAMINE AND N,N-DIETHYL-2-[I-125]IODOBENZYLAMINE AS POTENTIAL TOOLS FOR MONOAMINE UPTAKE EXPLORATION BY SPECT
    Journal of labelled compounds & radiopharmaceuticals
    
    C. Branger et al., "RADIOIODINATED ANALOGS OF XYLAMINE - N-(2-CHLOROETHYL)-N-ETHYL-2-[I-125]IODOBENZYLAMINE AND N,N-DIETHYL-2-[I-125]IODOBENZYLAMINE AS POTENTIAL TOOLS FOR MONOAMINE UPTAKE EXPLORATION BY SPECT", Journal of labelled compounds & radiopharmaceuticals, 36(7), 1995, pp. 685-699
74. POUSSET F; CHALON S; THOMARE P; DIQUET B; LECHAT P
    EVALUATION OF CARDIAC BETA(1)-ADRENERGIC SENSITIVITY WITH DOBUTAMINE IN HEALTHY-VOLUNTEERS
    British journal of clinical pharmacology
    
    F. Pousset et al., "EVALUATION OF CARDIAC BETA(1)-ADRENERGIC SENSITIVITY WITH DOBUTAMINE IN HEALTHY-VOLUNTEERS", British journal of clinical pharmacology, 39(6), 1995, pp. 633-639
75. BERLIN I; CHALON S; PAYAN C; SCHOLLNHAMMER G; CESSELIN F; VAROQUAUX O; PUECH AJ
    EVALUATION OF THE ALPHA(2)-ADRENOCEPTOR BLOCKING PROPERTIES OF BUSPIRONE AND IPSAPIRONE IN HEALTHY-SUBJECTS - RELATIONSHIP WITH THE PLASMA-CONCENTRATION OF THE COMMON METABOLITE 1-(2-PYRIMIDINYL)-PIPERAZINE
    British journal of clinical pharmacology
    
    I. Berlin et al., "EVALUATION OF THE ALPHA(2)-ADRENOCEPTOR BLOCKING PROPERTIES OF BUSPIRONE AND IPSAPIRONE IN HEALTHY-SUBJECTS - RELATIONSHIP WITH THE PLASMA-CONCENTRATION OF THE COMMON METABOLITE 1-(2-PYRIMIDINYL)-PIPERAZINE", British journal of clinical pharmacology, 39(3), 1995, pp. 243-249
76. DEMOLIS P; CHALON S; GIUDICELLI JF
    ACETAZOLAMIDE-INDUCED VASODILATION IN THE CAROTID VASCULAR BED IN HEALTHY-VOLUNTEERS
    Journal of cardiovascular pharmacology
    
    P. Demolis et al., "ACETAZOLAMIDE-INDUCED VASODILATION IN THE CAROTID VASCULAR BED IN HEALTHY-VOLUNTEERS", Journal of cardiovascular pharmacology, 26(5), 1995, pp. 841-844
77. CHALON S; BRUDI P; LECHAT P
    RESULTS OF CLINICAL-TRIALS ON REDUCTION O F HOLTER RECORDED MYOCARDIAL-ISCHEMIA
    Therapie
    
    S. Chalon et al., "RESULTS OF CLINICAL-TRIALS ON REDUCTION O F HOLTER RECORDED MYOCARDIAL-ISCHEMIA", Therapie, 50(2), 1995, pp. 123-129
78. CHALON S; ZOUAKIA A; SALIBA E; ZIMMER L; BESNARD JC; GUILLOTEAU D
    EVOLUTION OF STRIATAL DOPAMINE-RECEPTORS AFTER A NEONATAL HYPOXIC-ISCHEMIC INJURY IN THE RAT
    Pediatric research
    
    S. Chalon et al., "EVOLUTION OF STRIATAL DOPAMINE-RECEPTORS AFTER A NEONATAL HYPOXIC-ISCHEMIC INJURY IN THE RAT", Pediatric research, 38(3), 1995, pp. 430-430
79. SALIBA E; HUGUET F; CHALON S; TALLINEAU C; PIRIOU A; LAUGIER J
    DIHYDROPYRIDINE (DHP) BINDING-SITES CHARACTERISTICS IN THE BRAIN OF NEWBORN PIGLETS FOLLOWING HYPOXIA AND ISCHEMIA (HI)
    Pediatric research
    
    E. Saliba et al., "DIHYDROPYRIDINE (DHP) BINDING-SITES CHARACTERISTICS IN THE BRAIN OF NEWBORN PIGLETS FOLLOWING HYPOXIA AND ISCHEMIA (HI)", Pediatric research, 37(4), 1995, pp. 385-385
80. ZOUAKIA A; CHALON S; KUNG HF; DOGNON AM; SALIBA E; BESNARD JC; GUILLOTEAU D
    RADIOIODINATED TRACERS FOR THE EVALUATION OF DOPAMINE-RECEPTORS IN THE NEONATAL RAT-BRAIN AFTER HYPOXIC-ISCHEMIC INJURY
    European journal of nuclear medicine
    
    A. Zouakia et al., "RADIOIODINATED TRACERS FOR THE EVALUATION OF DOPAMINE-RECEPTORS IN THE NEONATAL RAT-BRAIN AFTER HYPOXIC-ISCHEMIC INJURY", European journal of nuclear medicine, 21(6), 1994, pp. 488-492
81. GARREAU L; OMBETTA JE; GALINIER E; DOGNON AM; CHALON S; FRANGIN Y; BESNARD JC; GUILLOTEAU D
    NEW RADIOLIGANDS FOR THE EXPLORATION OF DOPAMINE UPTAKE SITES BY SPET- DEVELOPMENT OF DERIVATIVES OF MAZINDOL - STRUCTURE AFFINITY RELATIONSHIP
    The Journal of nuclear medicine
    
    L. Garreau et al., "NEW RADIOLIGANDS FOR THE EXPLORATION OF DOPAMINE UPTAKE SITES BY SPET- DEVELOPMENT OF DERIVATIVES OF MAZINDOL - STRUCTURE AFFINITY RELATIONSHIP", The Journal of nuclear medicine, 35(5), 1994, pp. 160000247-160000247
82. GUILLOTEAU D; PELLEVOISIN C; CHALON S; MAZIERE B; SACCAVINI JC; BESNARD JC
    COMPARISON OF 3 SPECIFIC D2 DOPAMINE-RECEPTOR RADIOIODINATED LIGANDS IN ANIMAL-MODELS OF QUANTITATIVE RECEPTOR ALTERATIONS
    The Journal of nuclear medicine
    
    D. Guilloteau et al., "COMPARISON OF 3 SPECIFIC D2 DOPAMINE-RECEPTOR RADIOIODINATED LIGANDS IN ANIMAL-MODELS OF QUANTITATIVE RECEPTOR ALTERATIONS", The Journal of nuclear medicine, 35(5), 1994, pp. 160000257-160000257
83. SALIBA E; CHALON S; LAUGIER J
    EFFECT OF HYPOXIC-ISCHEMIC (H-I) BRAIN-DAMAGE ON GLUTAMATE RELEASE AND D1 MARKERS IN THE NEWBORN PIGLET
    Pediatric research
    
    E. Saliba et al., "EFFECT OF HYPOXIC-ISCHEMIC (H-I) BRAIN-DAMAGE ON GLUTAMATE RELEASE AND D1 MARKERS IN THE NEWBORN PIGLET", Pediatric research, 35(2), 1994, pp. 281-281
84. DELION S; CHALON S; HERAULT J; GUILLOTEAU D; BESNARD JC; DURAND G
    CHRONIC DIETARY ALPHA-LINOLENIC ACID DEFICIENCY ALTERS DOPAMINERGIC AND SEROTONINERGIC NEUROTRANSMISSION IN RATS
    The Journal of nutrition
    
    S. Delion et al., "CHRONIC DIETARY ALPHA-LINOLENIC ACID DEFICIENCY ALTERS DOPAMINERGIC AND SEROTONINERGIC NEUROTRANSMISSION IN RATS", The Journal of nutrition, 124(12), 1994, pp. 2466-2476
85. BERLIN I; ROSENZWEIG P; CHALON S; FUSEAU E; LANDAULT C; CESSELIN F; BLACKER C; PUECH AJ
    REDUCTION OF HYPERGLYCEMIA AFTER ORAL GLUCOSE-LOAD BY THE NEW ALPHA(2)-ADRENERGIC RECEPTOR ANTAGONIST SL84.0418 IN HEALTHY-SUBJECTS
    Clinical pharmacology and therapeutics
    
    I. Berlin et al., "REDUCTION OF HYPERGLYCEMIA AFTER ORAL GLUCOSE-LOAD BY THE NEW ALPHA(2)-ADRENERGIC RECEPTOR ANTAGONIST SL84.0418 IN HEALTHY-SUBJECTS", Clinical pharmacology and therapeutics, 55(3), 1994, pp. 338-345
86. GALINIER E; GARREAU L; DOGNON AM; OMBETTAGOKA JE; FRANGIN Y; CHALON S; BESNARD JC; GUILLOTEAU D
    SYNTHESIS OF HALOGENATED ANALOGS OF -2,3-DIHYDRO-5-HYDROXY-5H-IMIDAZO[2,1-A]-ISOINDOLE OR MAZINDOL FOR EXPLORATION OF THE DOPAMINE TRANSPORTER
    European journal of medicinal chemistry
    
    E. Galinier et al., "SYNTHESIS OF HALOGENATED ANALOGS OF -2,3-DIHYDRO-5-HYDROXY-5H-IMIDAZO[2,1-A]-ISOINDOLE OR MAZINDOL FOR EXPLORATION OF THE DOPAMINE TRANSPORTER", European journal of medicinal chemistry, 28(12), 1993, pp. 927-933
87. DEMOLIS P; CHALON S; GUIDICELLI JF
    REPEATABILITY TESTING FOR TRANSCRANIAL DOPPLER SONOGRAPHY - REPLY
    Clinical science
    
    P. Demolis et al., "REPEATABILITY TESTING FOR TRANSCRANIAL DOPPLER SONOGRAPHY - REPLY", Clinical science, 85(6), 1993, pp. 761-762
88. DEMOLIS P; CHALON S; GIUDICELLI JF
    REPEATABILITY OF TRANSCRANIAL DOPPLER MEASUREMENTS OF ARTERIAL BLOOD-FLOW VELOCITIES IN HEALTHY-SUBJECTS
    Clinical science
    
    P. Demolis et al., "REPEATABILITY OF TRANSCRANIAL DOPPLER MEASUREMENTS OF ARTERIAL BLOOD-FLOW VELOCITIES IN HEALTHY-SUBJECTS", Clinical science, 84(6), 1993, pp. 599-604
89. PELLEVOISIN C; CHALON S; ZOUAKIA A; DOGNON AM; FRANGIN Y; BAULIEU JL; BESNARD JC; GUILLOTEAU D
    COMPARISON OF 2 RADIOIODINATED LIGANDS OF DOPAMINE-D2 RECEPTORS IN ANIMAL-MODELS - IODOBENZAMIDE AND IODOETHYLSPIPERONE
    Life sciences
    
    C. Pellevoisin et al., "COMPARISON OF 2 RADIOIODINATED LIGANDS OF DOPAMINE-D2 RECEPTORS IN ANIMAL-MODELS - IODOBENZAMIDE AND IODOETHYLSPIPERONE", Life sciences, 52(23), 1993, pp. 1851-1860
90. PELLEVOISIN C; CHALON S; GUILLOTEAU D; BESNARD JC
    DIFFERENTIAL CHANGES IN STRIATAL D1 AND D2 DOPAMINE-RECEPTORS AFTER EXCITOTOXIN-INDUCED LESIONS IN RATS
    Journal of neurochemistry
    
    C. Pellevoisin et al., "DIFFERENTIAL CHANGES IN STRIATAL D1 AND D2 DOPAMINE-RECEPTORS AFTER EXCITOTOXIN-INDUCED LESIONS IN RATS", Journal of neurochemistry, 61, 1993, pp. 190000201-190000201